Personal tools

MCL coexpression mm9:106

From FANTOM5_SSTAR

Revision as of 16:15, 11 October 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:111668149..111668158,-p@chr10:111668149..111668158
-
Mm9::chr10:126918746..126918755,+p21@R3hdm2
Mm9::chr10:39338383..39338401,-p@chr10:39338383..39338401
-
Mm9::chr10:97030695..97030725,+p@chr10:97030695..97030725
+
Mm9::chr11:46503808..46503822,-p7@Timd2
Mm9::chr11:46564008..46564045,+p1@Havcr1
Mm9::chr11:46564064..46564079,+p2@Havcr1
Mm9::chr11:46564098..46564107,+p4@Havcr1
Mm9::chr11:46565908..46565916,+p@chr11:46565908..46565916
+
Mm9::chr11:68214559..68214578,-p10@Ntn1
Mm9::chr11:68214589..68214606,-p11@Ntn1
Mm9::chr12:104620760..104620761,-p@chr12:104620760..104620761
-
Mm9::chr12:104620776..104620787,-p@chr12:104620776..104620787
-
Mm9::chr12:80170796..80170800,+p@chr12:80170796..80170800
+
Mm9::chr12:92638878..92638892,+p@chr12:92638878..92638892
+
Mm9::chr12:92638906..92638917,+p@chr12:92638906..92638917
+
Mm9::chr12:92639430..92639462,+p1@Tshr
Mm9::chr12:92639464..92639478,+p2@Tshr
Mm9::chr12:92642462..92642493,+p@chr12:92642462..92642493
+
Mm9::chr13:27404521..27404525,+p2@Prl6a1
Mm9::chr13:32557315..32557329,+p@chr13:32557315..32557329
+
Mm9::chr13:61036161..61036172,-p@chr13:61036161..61036172
-
Mm9::chr13:61036176..61036186,-p@chr13:61036176..61036186
-
Mm9::chr13:61037911..61037930,-p1@Ctla2a
Mm9::chr13:61038143..61038148,-p3@Ctla2a
Mm9::chr13:95829053..95829071,-p@chr13:95829053..95829071
-
Mm9::chr14:35235900..35235910,-p@chr14:35235900..35235910
-
Mm9::chr14:35235937..35235940,-p@chr14:35235937..35235940
-
Mm9::chr14:41785917..41785953,+p@chr14:41785917..41785953
+
Mm9::chr14:41785974..41785977,+p@chr14:41785974..41785977
+
Mm9::chr14:56799615..56799618,-p@chr14:56799615..56799618
-
Mm9::chr14:56825210..56825237,+p@chr14:56825210..56825237
+
Mm9::chr15:73750444..73750448,+p@chr15:73750444..73750448
+
Mm9::chr16:20784809..20784812,-p@chr16:20784809..20784812
-
Mm9::chr16:20803423..20803434,-p@chr16:20803423..20803434
-
Mm9::chr16:30094079..30094085,+p@chr16:30094079..30094085
+
Mm9::chr16:92291354..92291359,+p@chr16:92291354..92291359
+
Mm9::chr16:96030326..96030329,-p1@ENSMUST00000156615
Mm9::chr17:25445587..25445592,+p1@Prss28
Mm9::chr17:25455594..25455602,+p1@Prss29
Mm9::chr17:35881045..35881083,-p@chr17:35881045..35881083
-
Mm9::chr17:35966913..35966936,+p5@Flot1
Mm9::chr17:69186402..69186433,+p1@Tmem200c
Mm9::chr18:68749095..68749099,-p@chr18:68749095..68749099
-
Mm9::chr19:29409136..29409142,-p1@Rln1
Mm9::chr19:55338956..55338996,+p@chr19:55338956..55338996
+
Mm9::chr1:164118982..164118990,-p@chr1:164118982..164118990
-
Mm9::chr1:170145614..170145620,-p@chr1:170145614..170145620
-
Mm9::chr1:174532714..174532721,-p3@Fcrl6
Mm9::chr1:17591974..17591994,+p1@Pi15
Mm9::chr1:188447625..188447635,-p@chr1:188447625..188447635
-
Mm9::chr1:188448176..188448182,-p@chr1:188448176..188448182
-
Mm9::chr1:188449089..188449095,-p@chr1:188449089..188449095
-
Mm9::chr1:188457900..188457913,-p@chr1:188457900..188457913
-
Mm9::chr1:188513246..188513289,-p@chr1:188513246..188513289
-
Mm9::chr1:188528872..188528902,-p4@Tgfb2
Mm9::chr1:188528892..188528901,+p@chr1:188528892..188528901
+
Mm9::chr1:188529773..188529798,+p@chr1:188529773..188529798
+
Mm9::chr1:188529859..188529878,-p1@Tgfb2
Mm9::chr1:188533348..188533350,+p@chr1:188533348..188533350
+
Mm9::chr1:40158220..40158223,+p@chr1:40158220..40158223
+
Mm9::chr1:52197272..52197276,-p@chr1:52197272..52197276
-
Mm9::chr1:54541662..54541686,-p@chr1:54541662..54541686
-
Mm9::chr2:7004903..7004922,-p@chr2:7004903..7004922
-
Mm9::chr2:75420503..75420506,+p@chr2:75420503..75420506
+
Mm9::chr3:107171294..107171301,+p@chr3:107171294..107171301
+
Mm9::chr3:107171302..107171307,+p@chr3:107171302..107171307
+
Mm9::chr3:107171337..107171347,+p@chr3:107171337..107171347
+
Mm9::chr3:121318996..121319004,-p@chr3:121318996..121319004
-
Mm9::chr3:131151965..131151985,-p@chr3:131151965..131151985
-
Mm9::chr3:131153693..131153706,-p@chr3:131153693..131153706
-
Mm9::chr3:131154017..131154021,-p@chr3:131154017..131154021
-
Mm9::chr3:131154239..131154252,-p@chr3:131154239..131154252
-
Mm9::chr3:131154291..131154300,-p@chr3:131154291..131154300
-
Mm9::chr3:131154350..131154362,-p@chr3:131154350..131154362
-
Mm9::chr3:131154363..131154373,-p@chr3:131154363..131154373
-
Mm9::chr3:131154401..131154412,-p@chr3:131154401..131154412
-
Mm9::chr3:131154523..131154532,+p@chr3:131154523..131154532
+
Mm9::chr3:142217879..142217886,+p@chr3:142217879..142217886
+
Mm9::chr4:114143506..114143510,-p@chr4:114143506..114143510
-
Mm9::chr4:141748867..141748871,-p@chr4:141748867..141748871
-
Mm9::chr4:149369914..149369920,-p@chr4:149369914..149369920
-
Mm9::chr5:113709567..113709589,-p4@Sgsm1
Mm9::chr5:113709592..113709626,-p2@Sgsm1
Mm9::chr5:136532993..136533001,+p11@2310043J07Rik
Mm9::chr5:136533008..136533013,+p9@2310043J07Rik
Mm9::chr5:143564663..143564666,-p@chr5:143564663..143564666
-
Mm9::chr5:20878514..20878532,+p1@Fgl2
Mm9::chr5:8808095..8808106,+p@chr5:8808095..8808106
+
Mm9::chr5:92691807..92691814,-p12@Naaa
Mm9::chr5:92691818..92691825,-p13@Naaa
Mm9::chr6:106679895..106679904,-p@chr6:106679895..106679904
-
Mm9::chr6:129457174..129457189,-p1@Olr1
Mm9::chr6:145024626..145024627,-p21@Bcat1
Mm9::chr6:38060420..38060425,-p@chr6:38060420..38060425
-
Mm9::chr6:38097441..38097447,-p13@D630045J12Rik
Mm9::chr6:38097449..38097457,-p16@D630045J12Rik
Mm9::chr6:65094976..65094993,-p4@Hpgds
Mm9::chr7:126744627..126744632,-p@chr7:126744627..126744632
-
Mm9::chr7:130565883..130565888,+p@chr7:130565883..130565888
+
Mm9::chr7:137388074..137388119,-p@chr7:137388074..137388119
-
Mm9::chr7:147276829..147276830,+p@chr7:147276829..147276830
+
Mm9::chr7:147279287..147279301,+p1@Prap1
Mm9::chr7:147282863..147282877,+p@chr7:147282863..147282877
+
Mm9::chr7:147282952..147282979,+p@chr7:147282952..147282979
+
Mm9::chr7:147283020..147283051,+p@chr7:147283020..147283051
+
Mm9::chr7:17319014..17319028,+p@chr7:17319014..17319028
+
Mm9::chr7:17319755..17319757,+p@chr7:17319755..17319757
+
Mm9::chr8:105871431..105871446,-p@chr8:105871431..105871446
-
Mm9::chr8:126016607..126016612,+p10@Afg3l1
Mm9::chr8:42187234..42187277,-p@chr8:42187234..42187277
-
Mm9::chr8:73107433..73107436,+p@chr8:73107433..73107436
+
Mm9::chr8:98020346..98020369,+p@chr8:98020346..98020369
+
Mm9::chr9:116079513..116079518,-p@chr9:116079513..116079518
-
Mm9::chr9:116084558..116084569,-p5@Tgfbr2
Mm9::chr9:122331238..122331246,+p@chr9:122331238..122331246
+
Mm9::chr9:28482580..28482586,+p@chr9:28482580..28482586
+
Mm9::chr9:85243991..85243994,-p@chr9:85243991..85243994
-
Mm9::chrX:71447751..71447759,+p@chrX:71447751..71447759
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005615extracellular space0.0132416920853748
GO:0044421extracellular region part0.0132416920853748
GO:0004263chymotrypsin activity0.0322211873847222
GO:0004295trypsin activity0.0322211873847222
GO:0007507heart development0.0322211873847222
GO:0002651positive regulation of tolerance induction to self antigen0.0322211873847222
GO:0002649regulation of tolerance induction to self antigen0.0322211873847222
GO:0004996thyroid-stimulating hormone receptor activity0.0322211873847222
GO:0002663positive regulation of B cell tolerance induction0.0322211873847222
GO:0001880Mullerian duct regression0.0322211873847222
GO:0002514B cell tolerance induction0.0322211873847222
GO:0045616regulation of keratinocyte differentiation0.0322211873847222
GO:0002661regulation of B cell tolerance induction0.0322211873847222
GO:0045617negative regulation of keratinocyte differentiation0.0322211873847222
GO:0048382mesendoderm development0.0322211873847222
GO:0004702receptor signaling protein serine/threonine kinase activity0.0348346947515786
GO:0030097hemopoiesis0.0366462529633387
GO:0008283cell proliferation0.0366462529633387
GO:0009309amine biosynthetic process0.0366462529633387
GO:0002666positive regulation of T cell tolerance induction0.0366462529633387
GO:0002643regulation of tolerance induction0.0366462529633387
GO:0004084branched-chain-amino-acid transaminase activity0.0366462529633387
GO:0002664regulation of T cell tolerance induction0.0366462529633387
GO:0002645positive regulation of tolerance induction0.0366462529633387
GO:0009082branched chain family amino acid biosynthetic process0.0366462529633387
GO:0002517T cell tolerance induction0.0366462529633387
GO:0040012regulation of locomotion0.0366462529633387
GO:0048534hemopoietic or lymphoid organ development0.0366462529633387
GO:0048518positive regulation of biological process0.0366462529633387
GO:0002520immune system development0.0426192840597251
GO:0060033anatomical structure regression0.0452589307795212
GO:0002513tolerance induction to self antigen0.0452589307795212
GO:0044271nitrogen compound biosynthetic process0.0455018767054064
GO:0007178transmembrane receptor protein serine/threonine kinase signaling pathway0.0459508849158139
GO:0007411axon guidance0.0459508849158139
GO:0005057receptor signaling protein activity0.0459508849158139
GO:0002507tolerance induction0.0459508849158139
GO:0009950dorsal/ventral axis specification0.0459508849158139
GO:0051138positive regulation of NK T cell differentiation0.0459508849158139
GO:0001865NK T cell differentiation0.0459508849158139
GO:0042416dopamine biosynthetic process0.0459508849158139
GO:0051136regulation of NK T cell differentiation0.0459508849158139
GO:0005102receptor binding0.0463596873818624
GO:0030098lymphocyte differentiation0.0495436465649074



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>



TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}